@article {239, title = {Virtual Pediatrics Medication Counseling Clinic: A New Initiative Project in Saudi Arabia}, journal = {PTB Reports}, volume = {9}, year = {2023}, month = {November 2023}, pages = {28-33}, type = {Review Article}, chapter = {28}, abstract = {

Objectives: The virtual pediatric medication counseling clinics were created to align with Saudi Vision2030. This topic aims to declare the virtual pediatric medicine education clinic services as a new initiative in the Kingdom of Saudi Arabia. Methods: This new project is driven by local and international virtual pharmaceutical care services. It was formulated from guidelines of pharmacy projects, the international business model, , and management institution guidelines for the new project. Project management professionals draft this initiative, consisting of several stages, from the initial until planning phases, execution, monitoring, and control stages. Results: Virtual pediatric medicine counseling clinics consist of medication history reviews, medication reconciliation, patient education, medication safety, research and development, and patient satisfaction. Furthermore, the risk management model description ensures the project{\textquoteright}s continuation. Besides, the monitoring and control of the services were declared. Finally, the analysis investigates the transition to the operation project through the closing project stage. Conclusion: Virtual pediatric medication counseling clinics are a new initiative in the general strategic plan with Saudi Vision 2030. Virtual pediatric medicine education clinic requires a clear vision, policy and procedures, and long-term patient service satisfaction. Virtual pediatric medication counseling clinics may be essential in developing an appropriate pharmacy professional plan focusing on patient care to achieve targeted therapeutic management, prevent drug-related problems, and avoid unnecessary costs.

}, keywords = {Counseling, Education, Medication, Saudi Arabia., Virtual Pediatric}, doi = {10.5530/PTB.2023.9.5}, author = {Nouf Musleh Alassadi and Asma Mohammed Alzahrani and Haifa Shabeeb Almutairi and Tahani Mohammed Alotaibi and Mona Yousef Lubbad and Nouf Abdurazaq Alhaza and Raghad Maluoh Alanazi and Yousef Ahmed Alomi} } @article {130, title = {Antipsychotic medication therapy during the holy month of Ramadan: a literature review}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {5}, year = {2019}, month = {July 2019}, pages = {79-83}, type = {Review Article}, chapter = {79}, abstract = {

Objectives: To review the antipsychotic medication therapy during the holy month of Ramadan. Methods: In this study, we performed an extensive search of 50 databases through the Saudi Digital Library search engine. We included meta-analysis, randomized controlled studies and observational studies published in English language in May 2017. The search terms included Ramadan, fasting, medication, therapy, type of disease, and medication based on therapeutic class. The search on antipsychotic and anti-epileptic medication list and switch from regular days to Ramadan days included comparative safety, efficacy and cost of type of medication for each disease and national or international evidencebased guidelines including those switching short half-life to long half-life drugs. All nonoral dosage form of medication will be excluded in this study. All medications should be documented in the Ministry of Health drug formulary. Results: A total of 710 studies were shortlisted after an extensive search with specific terms. Of those, 104 studies were duplicate studies; therefore only 606 studies were included for further evaluation. The evaluation revealed that 27 studies discussed about the antipsychotic medications and Ramadan. Of these, only five were appropriate for further revision. According to our results, most of the studies were observational studies and a few have conducted experimental design studies. Three studies have a shared or similar study design (i.e., reports). Among all the reports analyzed in this study, most of them used study design. On the contrary, three studies mentioned the utilization of a descriptive approach; however, none of the studies mentioned the exact type of descriptive analysis conducted. One study was a clinical review and another study mentioned the applicability of a randomized controlled trial. Based on this, the authors suggested switching the antipsychotic and anti-epileptic medication from regular days to Ramadan days. Conclusion: There are no randomized clinical trials in the literature to validate the switching of medication from regular to Ramadan days. A list of antipsychotic medications that can be used to switch during Ramadan is highly warranted. Further studies to validate the medication used to treat psychiatric conditions during the holy month of Ramadan is recommended.

}, keywords = {Antipsychotic, Medication, Ramadan, Review, Therapy}, doi = {10.5530/PTB.2019.5.14}, author = {Yousef Ahmed Alomi and Jude Alhowaidi and Raneem Alzeer and Ali Alhowaidi and Nora Alhowaidi} } @article {128, title = {Cardiovascular medication therapy during the holy month of Ramadan: a literature review}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {5}, year = {2019}, month = {July 2019}, pages = {69-74}, type = {Review Article}, chapter = {69}, abstract = {

Objectives: To review cardiovascular medication therapy during the Holy month of Ramadan. Methods: In this study, we performed an extensive search of 50 databases through the Saudi Digital Library search engine. We included meta-analysis, randomized controlled studies and observational studies published in English language in May 2017. The search terms included Ramadan, fasting, medication, therapy, type of disease and medication based on therapeutic class. The list of cardiovascular medications and switch from regular days to Ramadan days based on literature revealed that{\textquoteright}s included comparative safety studies, efficacy and cost of type of medication for each disease studies and national or international evidence-based guidelines of switching short half-life to long half-life. All parenteral dosage form of medication were excluded from this study. All medications should be listed in the Ministry of Health drug formulary. Results: A total of 710 studies were obtained after an extensive search with specific terms. Of those, 104 studies were duplicate studies and 606 studies were included for further evaluation. The evaluation revealed that there were 30 studies published on cardiovascular medications and Ramadan. Seven studies were further evaluated. The authors recommend to have a list of cardiovascular medications that can be switched from regular days to Ramadan days. Conclusion: There were very studies about cardiovascular medications use during the holy month of Ramadan. Suggested usage of the frequency administration single or twice daily is required during fasting. Future investigations of cardiovascular medication intake during Ramadan is highly recommended in Muslim countries.

}, keywords = {Cardiovascular, Medication, Review, Therapy}, doi = {10.5530/PTB.2019.5.12}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar} } @article {146, title = {Cost Analysis of Delivery Adult Medication Therapy Services at Ministry of Health in Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {5}, year = {2019}, month = {September 2019}, pages = {S1-S3}, type = {Research Article}, chapter = {S1}, abstract = {

Objectives: The aim of this study is to explore the cost analysis of drug delivery therapy services for adults{\textquoteright} population at Ministry of Health in Saudi Arabia by using American Model with local cost. Methods: It is a cross-sectional 6-months analysis of drug distribution services for adult patients conducted in 2016. It was at 300-bed maternity and pediatrics hospital in Riyadh, Saudi Arabia. The cost calculated adults drug therapy management services delivered to 144 beds. The physician prescribed the medications. The pharmacist reviewed and prepared drugs and distributed through the unit dose system, floor stock distribution and discharge medication services. The fast-moving oral and topical medications were included in the study. The cost model was calculated based on variable expenses including personal cost, material and supply cost. The fixed cost was including direct cost, non-salary cost and overhead cost. All cost was used of US dollar currency and local prices. Results: The estimated cost of drug delivery therapy services for all total number adults{\textquoteright} beds per day was (1,191.965 USD). It contained three types; the unit dose system (761.35 USD), drug floor stock distribution system (334.99 USD) and discharge medication system (95.62 USD). The cost of delivery of medicines to single bed per day was (13.99 USD) with the highest estimated cost of delivery from discharge medication (6.37 USD), followed by unit dose services (5.29 USD) and floor stock therapy (2.33 USD). The total estimated annual expenditures of drug distribution services were (435,067.15 USD). Conclusion: In this adults medication therapy services cost-estimation the first study was conducted at MOH in Saudi Arabia. It is an essential necessary element of the Pharmacoeconomic program and implements Saudi{\textquoteright}s future vision 2030 for drug therapy health care services.

}, keywords = {Adult, Cost, Delivery, Distrubution, Medication, Ministry of Health, Saudi Arabia, Services, Therapy}, doi = {10.5530/PTB.2019.5.28}, author = {Yousef Ahmed Alomi and Malika Alhadab and Tahani Alotaibi} } @article {148, title = {Cost-effectiveness Analysis of Medication Safety Program at Pediatrics, Obstetrics and Gynecology Hospital, East Province, Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {5}, year = {2019}, month = {September 2019}, pages = {S12-S16}, type = {Research Article}, chapter = {S12}, abstract = {

Objectives: Medication safety program initiated at East Province of Ministry of Health in 2013. The pharmacist prevents all drug related problems. To improve continuity of care at hospital admission, discharge and to diminution medication errors medication safety programs are established. The objective of this study was to evaluate the cost-effectiveness of the Medication Safety program at the hospital in East province, Saudi Arabia by using International Study Model. Methods: This cross-sectional study with a 12-month recruitment period was conducted in a 500-bed Pediatrics, Obstetrics and Gynecology Hospital through preventing and documentation of medication errors in adults and pediatrics at Ministry of Health hospitals in 2015. The hospital had medication safety officer with medication safety committee. The program led by trained pharmacist and delivered basic patient safety in medical education to all healthcare professionals. The expected cost calculated using International Study Model, expressed in United State Dollars (USD), the cost measured were the expected results of medication errors outcome if not stopped; starting from ambulatory care visit or community pharmacy, additional laboratory test, hospital or critical care admission or even death complications. Results: The total number of prevented medication errors were 2071 at 827 prescribed to 827 patients with an estimated cost avoidance of avoiding medication was (116,228.41 USD) annually. The most estimated cost avoidance was prescriber related and general errors was 99.12\% (115.201.9 USD). The pharmacist avoided medication errors with estimated cost avoidance of drug related problem (140.54 USD) per each prescription and (56.12 USD) per error. The most common categories of medications cost avoidance were Musculoskeletal and joint disease (8,397.2 USD) followed by Infections (5,731.17 USD) and Nutrition class (4,717.99 USD). The highest drug of cost avoidance were Insulin injection (39,964.32 USD), iron tablet (11,526.9 USD) folic acid tablet (11,526.9 USD) and calcium tablet (11,526.9 USD) and Enoxaparin injection (9,637.02 USD). There were three high-risk medication founded with Insulin, Enoxaparin and Heparin errors with (42.9\%) of annual total cost avoidance. Conclusion: Medication safety program is a cost-efficiency replication at Pediatrics, Obstetrics and Gynecology Hospital in Saudi Arabia, prevents medication misadventures, improve patient safety and education. Growing drug safety program related with preventing drug-related problems and cost avoidance replication for Healthcare improvement, better care and better patient consequences.

}, keywords = {Cost, Efficiency, Medication, Ministry of Health, Obstetrics and Gynecology, Pediatrics, Safety, Saudi Arabia}, doi = {10.5530/PTB.2019.5.31}, author = {Yousef Ahmed Alomi and Amal Ahmad Alanazi and Mohammed Mohsen Almaznai and Fatimah Ali Albusalih} } @article {147, title = {Cost-Efficiency of Medication Safety Program at Public Hospital, Riyadh, Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {5}, year = {2019}, month = {September 2019}, pages = {S4-S8}, type = {Research Article}, chapter = {S4}, abstract = {

Objectives: Medication safety program started at Riyadh city of Ministry of Health in 2014. Identifying, resolving and preventing drug therapy problems are the unique contributions of the pharmaceutical care practitioner. The research aimed to estimate cost-efficiency of Medication Safety program at the hospital in East province, Saudi Arabia by using American model of pharmacist intervention cost avoidance. Methods: This cross-sectional study with a 9-month recruitment period was conducted in a 300-bed public hospital through preventing and documentation of medication errors in adults and pediatrics at Ministry of Health hospitals in 2015. The program led by trained pharmacist and delivered basic patient safety in medical education to all healthcare professionals. The predictable cost calculated using International Study Model, expressed in USD, the cost measured were the expected results of medication errors outcome if not stopped; starting from physician visit, additional laboratory test, further treatment, hospital admission and critical care admission to death stage. Results: The total number of prevented medication errors were 3,378 at 805 prescribed to 805 patients with an estimated cost avoidance of avoiding medication errors was (98,195.97 USD) for the study period and (10,910 USD) per month. The pharmacist avoided medication errors with estimated cost avoidance of drugrelated problem (29 USD) per each mistake and (122 USD) per prescription and patient. The most type inquiries estimated cost avoidance was prescribing stage 86,939.05 USD (99.86\%), followed by drugrelated errors 7,061.26 USD (7.2\%) and dosage form-related errors 6,084.98 USD (6.2\%). The highest drug of cost avoidance were Musculoskeletal and joint disease (8,397.2 USD) followed by Infections (5,731.17 USD) and Nutrition (4,717.99 USD), while the largest drug of cost avoidance was Paracetamol Injection (5,812.17 USD), followed by oral Ferrous Sulfate (3,562.79 USD) and Ceftriaxone 1g (2,861.70 USD). Conclusion: Medication safety program is a cost-efficiency simulation at the public hospital in Saudi Arabia, prevents medication disasters, improve patient safety. Increasing drug safety program associated with preventing drug-related problems and cost avoidance simulation for Healthcare development and better care and better patient consequences.

}, keywords = {Cost-efficiency, Hospital, Medication, Ministry of Health, Public, Riyadh, Safety, Saudi Arabia}, doi = {10.5530/PTB.2019.5.29}, author = {Yousef Ahmed Alomi and Mona Awad Alanazi and Radi Abdullah Alattyh and Fatimah Ali Albusalih} } @article {126, title = {Medication therapy during the holy month of Ramadan}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {5}, year = {2019}, month = {July 2019}, pages = {56-64}, type = {Review Article}, chapter = {56}, abstract = {

Objectives: In this study, we aimed to explore the switching of oral drug therapy from regular days to the Ramadan days. Methods: We performed extensive search on 50 databases. Studies such as meta-analysis, randomized controlled studies and observational studies published in English language with human participants during the month of May 2017 were included in this study. The search terms included {\textquotedblleft}Ramadan, fasting and medication,{\textquotedblright} {\textquotedblleft}Therapy and type of disease,{\textquotedblright} or {\textquotedblleft}Medication based on therapeutics class.{\textquotedblright} The medication list used to switch the medications from regular days to Ramadan days. It was based on best literature found. The literature included the comparative safety and efficacy studies and cost of type of medication for each disease studies and national or international evidence-based guidelines of switching short half-life medications to long half-life. The medication list included drug name, general dosing and frequency of administration during regular and Ramadan days. All medications should be registered at the Ministry of Health (MOH) drug formulary or registered in the Saudi Food and Drug Authority. Results: A total of 710 were shortlisted based on the extensive search with specific terms. Of those, 104 were duplicate studies and therefore were omitted from further analysis. A total of 606 studies were unique and were further evaluated. Ninety-two studies discussed about medications related to diabetes mellitus and Ramadan; 27 studies discussed about the anti-psychiatric medications and Ramadan; 27 studies investigated gastrointestinal medications and Ramadan; 30 studies discussed about the various antibiotics and Ramadan; 30 studies discussed about the cardiovascular medications and Ramadan; 15 studies discussed about the medications for asthma and rheumatoid arthritis and Ramadan; and finally, 402 studies discussed about other diseases and Ramadan. There were no randomized controlled studies regarding switching of drug dosing from regular days to Ramadan days. The suggested draft about switching of 171 drug therapy from regular to the holy month of Ramadan designed and registration status in the MOH formulary and Kingdom of Saudi Arabia based on the best available literature from common illnesses including cardiovascular diseases, infectious diseases and psychiatric illness. Conclusion: The literature of drug therapy during Ramadan is seldom found and there is no randomized clinical trial to validate the usage of medication during Ramadan. This is the review of medication used for common diseases infectious diseases, cardiovascular system, psychiatry and gastrointestinal system during the holy month of Ramadan with the first suggestion draft of switch drug therapy from regular days to Ramadan days.

}, keywords = {Medication, Ramadan, Therapy}, doi = {10.5530/PTB.2019.5.10}, author = {Yousef Ahmed Alomi and Sultan Mohammed Al-Jarallah and Aljohara Abdullah Adouh and Meshael Ibrahim Alghuraibi} } @article {119, title = {National Survey of Medication Safety Practice: Environmental Culture and Staff Competency at Primary Healthcare Centers/ Community Pharmacies in Riyadh, Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {5}, year = {2019}, month = {January 2019}, pages = {20-27}, type = {Research Article}, chapter = {20}, abstract = {

Objective: To explore the national survey of medication safety practices with an emphasis on environmental factors and staff competencies at primary healthcare centers (PHCs) and community pharmacies (CPs) in Saudi Arabia, Riyadh city. Method: This is a 4-month cross-sectional medication safety practice survey conducted at pharmacies of PHCs of Ministry of Health and CPs in Riyadh city. The survey consisted of the modified version of the Medication Safety Self-Assessment{\textregistered} for Community/ Ambulatory Pharmacy from the Institute of Safe Medication Practices (ISMP). The survey consisted of a demographic section and 10 domains with questions on environmental factors, staff competency and education. The authors distributed the questionnaire and followed-up on a daily basis by physically visiting or via telephonic call. The survey was prepared in an electronic format and it was analyzed through the Survey Monkey system and Microsoft Excel version 10. Result: The survey was distributed to 13 PHCs and 23 CPs. The average score of all the ISMP-self assessment of medication safety items at PHCs was 2.75 {\textpm} 0.36 (54.94\%) (95\% confidence interval (95\% CI) = 2.55{\textendash}2.95; P\<0.05; range = 2.04{\textendash}3.38). The average score of all ISMP-self assessment of medication safety items at CPs was 3.14 {\textpm} 0.42 (62.86\%) (95\% CI = 2.90{\textendash}4.38; P\<0.05; range = 2.40{\textendash}3.88). The average score of environmental factors, workflow and staffing domain at PHCs was 2.7 {\textpm} 0.45 (54\%) (95\% CI = 2.53{\textendash}2.87; P\<0.05; range = 1.55{\textendash}3.68), whereas in CPs, the average score was 3.58 {\textpm} 0.43 (71.6\%) (95\% CI = 3.44{\textendash}3.717; P\<0.05; range = 2.63{\textendash}4.37). The average score of staff competency and education at PHCs was 3.02 {\textpm} 0.298 (60.4\%) (95\% CI = 2.9{\textendash}3.2; P\<0.05; range = 2.64{\textendash}3.55), whereas in the CPs, the average score was 4.15 {\textpm} 0.20 (83\%) (95\% CI = 4.03{\textendash}4.27; P\<0.05; range = 3.78{\textendash}4.53). Conclusion: The PHCs implemented only half of the environmental factors, workflow and staff competency domains preventive measures for medication safety and lower than CPs. Targeting of improving environmental culture and staff competency for medication safety at PHCs is highly recommended in KSA.

}, keywords = {Community Pharmacy, Environmental culture, Medication, Primary Healthcare Centers, Riyadh, Safety, Saudi Arabia, Staff competency}, doi = {10.5530/PTB.2019.5.5}, author = {Yousef Ahmed Alomi and Zainab Abdulmunem Almuallem and Manar Mohammed Alslim and Rana Mohammed Alslim and Khulud Abdulrahman Alamoudi and Adel Mehmas Hamdi Alragas} } @article {120, title = {National Survey of Medication Safety Practice: Medication Administration at Primary Healthcare Centers/Community Pharmacies in Riyadh, Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {5}, year = {2019}, month = {January 2019}, pages = {28-35}, type = {Research Article}, chapter = {28}, abstract = {

Objective: To explore the national medication safety practice with emphasis on medication administration at primary healthcare centers (PHCs) and community pharmacies (CPs) in Riyadh city, Kingdom of Saudi Arabia. Methods: This is a four-month cross-sectional medication safety practice survey conducted at PHC pharmacies and CPs in Riyadh city. The survey consisted of the modified version of the Medication Safety Self-Assessment{\textregistered} for Community/Ambulatory Pharmacy from the Institute of Safe Medication Practice (ISMP). The survey consisted of a demographic section and 10 domains with 198 questions. The domains included questions on patient information; drug information; communication of drug orders and other drug information; drug labeling and packaging and nomenclature; use of devices; environmental factors; staff competency and education; patient education; quality processes; and risk management domain. In this study, we emphasized on medication administration; it is a finding from medication safety self-assessment for community/ambulatory pharmacy in Riyadh city. Results: The survey was distributed to 13 PHC pharmacies and 23 CPs. The average score of all ISMP-self assessment items of medication safety at PHCs was 2.75{\textpm}0.36 (54.94\%) (95\% CI=2.55{\textendash} 2.95; P\<0.05; range=2.04{\textendash}3.38). The average score of all ISMP-self assessment items of medication safety at CPs was 3.14{\textpm}0.42 (62.86\%) (95\% CI=2.90{\textendash}4.38; P\<0.05; range=2.40{\textendash}3.88). The average score of drug standardization, storage and distribution domain at PHCs was 2.35{\textpm}0.41 (47\%) (95\% CI=2.17{\textendash}2.53; P\<0.05; range=1.33{\textendash}3.09) and in CPs, it was 3.4{\textpm}0.54 (68\%) (95\% CI =3.16{\textendash}3.54; P\<0.05; range=2.22{\textendash}4.25). The average score of medication devices acquisition, use and monitoring domain at PHCs was 3.62{\textpm}0.14 (72.4\%) (95\% CI=3.26{\textendash}3.978; P\<0.05; range=3.45{\textendash}3.70) and in CPs, it was 2.78{\textpm}0.23 (55.6\%) (95\% CI=2.21{\textendash}3.349; P\<0.05; range=2.63-3.05). Conclusion: The medication administration safety was inadequate at PHCs while acceptable at CPs. Targeting to drug standardization, storage and distribution with emphasis on medication devices use and monitoring are highly recommended at PHCs in the Kingdom of Saudi Arabia.

}, keywords = {Administration, Community Pharmacy, Medication, Primary care centers, Riyadh, Safety, Saudi Arabia}, doi = {10.5530/PTB.2019.5.6}, author = {Yousef Ahmed Alomi and Adel Mehmas Hamdi Alragas and Manar Mohammed Alslim and Khulud Abdulrahman Alamoudi and Zainab Abdulmunem Almuallem and Rana Mohammed Alslim} } @article {121, title = {National Survey of Medication Safety Practice: Patient Education, Quality Process and Risk Management at Primary Healthcare Centers/Community Pharmacies in Riyadh, Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {5}, year = {2019}, month = {January 2019}, pages = {36-43}, type = {Research Article}, chapter = {36}, abstract = {

Objective: To explore the national medication safety practice such as patient education, quality process and risk management at primary healthcare centers (PHCs) and community pharmacies (CPs) in Riyadh city, Kingdom of Saudi Arabia. Methods: This is a four-month cross-sectional medication safety practice survey conducted at PHC pharmacies and CPs in Riyadh city. The survey consisted of the modified version of the Medication Safety Self-Assessment{\textregistered} for Community/Ambulatory Pharmacy from the Institute of Safe Medication Practice (ISMP). The survey consisted of a demographic section and 10 domains with 198 questions. The domains included questions on patient information; drug information; communication of drug orders and other drug information; drug labeling and packaging and nomenclature; use of devices; environmental factors; staff competency and education; patient education; quality processes; and risk management domain. In this study, we emphasized on patient education, quality process and risk management; it is a finding from medication safety self-assessment for community/ ambulatory pharmacy in Riyadh city. Results: The survey was distributed to 13 PHC pharmacies and 23 CPs. The average score of all ISMP-self assessment of medication safety items at PHCs was 2.75{\textpm}0.36 (54.94\%) (95\% confidence interval (95\% CI)=2.55{\textendash}2.95; P\<0.05; range=2.04{\textendash}3.38). The average score of all ISMP-self assessment of medication safety items at CPs was 3.14{\textpm}0.42 (62.86\%) (95\% CI=2.90{\textendash}4.38; P\<0.05; range=2.40{\textendash}3.88). The average score of patient education at PHCs was 3.04{\textpm}0.365 (60.8\%) (95\% CI=2.89{\textendash}3.19; P\<0.05; range=2.00{\textendash}3.73) and at CPs, it was 3.73{\textpm}0.29 (74.6\%) (95\% CI=3.61{\textendash}3.85; P\<0.05; range=3.11{\textendash}4.22). The average score of quality processes and risk management at PHCs was 2.76{\textpm}0.35 (55.2 \%) (95\% CI=2.64{\textendash}2.88; P\<0.05; range=2.09{\textendash}3.50) and at CPs, it was 3.20 {\textpm}0.38 (64\%) (95\% CI=3.07{\textendash}3.33; P\<0.05; range=2.47{\textendash}3.89). Conclusion: The implementation of patient education and quality processes and risk management at PHCs and CPs were inadequate. Targeting to improve all meditations safety assessment tools at PHCs and CPs is highly recommended in the Kingdom of Saudi Arabia.

}, keywords = {Community Pharmacies, Education, Medication, Primary Healthcare Centers, Quality, Risk Management, Riyadh, Safety, Saudi Arabia}, doi = {10.5530/PTB.2019.5.7}, author = {Yousef Ahmed Alomi and Zainab Abdulmunem Almuallem and Manar Mohammed Alslim and Khulud Abdulrahman Alamoudi and Adel Mehmas H. Alragas and Rana Mohammed Alslim} } @article {109, title = {National Survey of Medication Safety Practice: Drug Information at Primary Healthcare Centers/Community Pharmacies in Riyadh, Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {4}, year = {2018}, month = {September 2018}, pages = {37-42}, type = {Research Article}, chapter = {37}, abstract = {

Objective: To explore regarding drug information at Primary Healthcare Centers (PHCs) and Community Pharmacies (CPs) in Riyadh city, Kingdom of Saudi Arabia. Methods: This is a 4-month crosssectional survey conducted at PHCs and CPs in Riyadh city. In this study, the survey was adapted and modified from the Institution of Safe Medication Practice (ISMP) medication safety self-assessment for community/ambulatory pharmacy. It consists of a demographic section and 10 domains with 198 questions. The domains captured the following information: patient information; drug information; communication of drug orders and other drug information; drug labeling and packaging and nomenclature; use of medication delivery devices; environmental factors; staff competency and education; patient education; quality processes; and risk management domain. The survey was conducted at PHCs of Ministry of Health and at CPs located in Riyadh city. This study is focused on the second domain, that is, drug information at PHCs and CPs in Riyadh city. Results: The survey was distributed to 13 PHCs and 23 CPs. The average {\textpm} Standard Deviation (SD) of all ISMP-self assessment items of medication safety practice at PHCs was 2.75{\textpm}0.36 (54.94\%) (95\% Confidence Interval (CI) = 2.55{\textendash}2.95; P\<0.05; range = 2.04{\textendash}3.38). The average score of all ISMP-self assessment items of medication safety practice at CPs was 3.14{\textpm}0.42 (62.86\%) (95\% CI = 2.90{\textendash}4.38; P\<0.05; range = 2.40{\textendash}3.88). The average score of drug information domain at PHCs was 2.04{\textpm}0.34 (40.8\%) (95\% CI = 1.89{\textendash}2.19; P\<0.05; range = 1.50{\textendash}2.73), whereas that at the CPs was 2.35{\textpm}0.5 (47\%) (95\% CI = 2.13{\textendash}2.57; P\<0.05; range = 1.61{\textendash}3.43). Conclusion: The PHCs and CPs need to improve the key aspects of drug information related to the safety documentation and reporting system for medications. We recommend that the PHCs and CPs in the Kingdom of Saudi Arabia (KSA) should regularly conduct awareness programs on medication safety. We also recommend conducting an annual follow-up assessment of all the critical elements of drug information related to the medication safety system at PHCs and CPs.

}, keywords = {Community Pharmacies, Drug Information, Medication, Primary Healthcare Centers, Riyadh, Safety, Saudi Arabia}, doi = {10.5530/PTB.2018.4.13}, author = {Yousef Ahmed Alomi and Manar Mohammed Alslim and Rana Mohammed Alslim and Khulud Abdulrahman Alamoudi and Zainab Abdulmunem Almuallem and Adel Mehmas H. Alragas} } @article {110, title = {National Survey of Medication Safety Practice: Patient Information at Primary Healthcare Centers/Community Pharmacies in Riyadh, Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {4}, year = {2018}, month = {September 2018}, pages = {43-48}, type = {Research Article}, chapter = {43}, abstract = {

Objective: To explore patient{\textquoteright}s information regarding national medication safety Practice At Primary Healthcare Centers (PHCs) and Community Pharmacies (CPs) in Riyadh city, Kingdom of Saudi Arabia. Methods: This is a 4-month cross-sectional survey conducted on medication safety practice at PHCs and CPs in Riyadh city. In this study, the survey was adapted and modified from the Institution of Safe Medication Practice (ISMP) medication safety self-assessment for community/ambulatory pharmacy. It consists of a demographic section and 10 domains with 198 questions. The domains captured the following information: patient information; drug information; communication of drug orders and other drug information; drug labeling, packaging and nomenclature; use of medical devices; environmental factors; staff competency and education; patient education; quality processes; and risk management domain. The survey was conducted at the PHCs of the Ministry of Health and at CPs located in Riyadh city. This study is focused on the first domain, that is, patient information in PHCs and CPs in Riyadh city. Results: The survey was distributed to 13 PHCs and 23 CPs. The average {\textpm} Standard Deviation (SD) of all ISMP-self assessment items of medication safety practice at PHCs was 2.75{\textpm}0.36 (54.94 \%) (95\% confidence interval (95\% CI) = 2.55{\textendash}2.95; P\<0.05; range = 2.04{\textendash}3.38). The average {\textpm} SD score of all ISMP-self assessment items of medication safety practice at CPs was 3.14{\textpm}0.42 (62.86\%) (95\% CI = 2.90{\textendash}4.38; P\<0.05; range = 2.40{\textendash}.88). The average {\textpm} SD score of patient information at PHCs was 2.80{\textpm}0.467 (56 \%) (95\% CI = 2.54{\textendash}3.58; P\<0.05; range = 2.08{\textendash}3.45), whereas that of the CPs was 2.60{\textpm}0.667 (52 \%) (95\% CI = 2.23{\textendash}2.97; P\<0.05; range = 1.36{\textendash}3.96). Conclusion: The PHCs and PCs implemented almost half the of ISMP medication safety critical elements including the patient information related issue. Targeting to improve medication safety system at PHCs and CPs is highly recommended in the Kingdom of Saudi Arabia

}, keywords = {Community Pharmacy, Information, Medication, Patient, Primary Healthcare Center, Riyadh, Safety, Saudi Arabia.}, doi = {10.5530/PTB.2018.4.14}, author = {Yousef Ahmed Alomi and Rana Mohammed Alslim and Manar Mohammed Alslim and Khulud Abdulrahman Alamoudi and Zainab Abdulmunem Almuallem and Adel Mehmas H. Alragas} }